Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4A | O75164 | 4/20 | 0.37 |
| ▸ | KDM2A | Q9Y2K7 | 4/20 | 0.37 |
| ▸ | AHR | P35869 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | RELA | Q04206 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1326473 | 1.00 | KDM4A (0.37) | KDM4AKDM2AAHRCYP2C9CYP3A4 | |
| SCHEMBL10597262 | 0.79 | ESR1 (0.46) | CYP3A4PTGS1PTGS2ALDH1A1KMT2A | |
| SCHEMBL8726009 | 0.79 | ESR1 (0.46) | CYP3A4PTGS1PTGS2ALDH1A1KMT2A | |
| SCHEMBL3432777 | 0.79 | ALDH1A1 (0.44) | CYP2C9CYP3A4CYP2D6CYP1A2CYP2C19 | |
| SCHEMBL3432776 | 0.79 | ALDH1A1 (0.44) | CYP2C9CYP3A4CYP2D6CYP1A2CYP2C19 | |
| SCHEMBL9332414 | 0.78 | — | — | |
| SCHEMBL9332407 | 0.78 | — | — | |
| SCHEMBL3195894 | 0.77 | ALDH1A1 (0.42) | KCNH2ALDH1A1KMT2ATP53SMN1; SMN2 | |
| SCHEMBL10431203 | 0.77 | ALDH1A1 (0.42) | KCNH2ALDH1A1KMT2ATP53SMN1; SMN2 | |
| SCHEMBL10431202 | 0.77 | ALDH1A1 (0.42) | KCNH2ALDH1A1KMT2ATP53SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0819305-B1 | LIQUID CRYSTAL OPTICAL STORAGE MEDIUM WITH GRAY SCALE | ELSICON INC (US) | 2004-11-17 | — | — | EP | claimed |
| US-5846452-A | Liquid crystal optical storage medium with gray scale | ALLIANT TECHSYSTEMS INC. (US) | 1998-12-08 | — | — | US | claimed |
| EP-0387059-B1 | Process of aligning liquid crystal media | HERCULES INC (US) | 1998-06-10 | — | — | EP | claimed |
| EP-0819305-A1 | LIQUID CRYSTAL OPTICAL STORAGE MEDIUM WITH GRAY SCALE | ALLIANT TECHSYSTEMS INC. (US) | 1998-01-21 | — | — | EP | claimed |
| WO-1996031876-A1 | LIQUID CRYSTAL OPTICAL STORAGE MEDIUM WITH GRAY SCALE | ALLIANT TECHSYSTEMS INC. (US) | 1996-10-10 | — | — | WO | claimed |
| US-5032009-A | Polarized light exposure | HERCULES INCORPORATED (US) | 1991-07-16 | — | — | US | claimed |
| US-4974941-A | Process of aligning and realigning liquid crystal media | HERCULES INCORPORATED (US) | 1990-12-04 | — | — | US | claimed |
| EP-0387059-A2 | Process of aligning liquid crystal media | HERCULES INCORPORATED (US) | 1990-09-12 | — | — | EP | claimed |
| US-12044872-B2 | Method for generating alignment on top of a liquid crystal polymer material | Rolic Technologies AG (CH) | 2024-07-23 | — | — | US | disclosed |
| US-12012382-B2 | Polymerizable liquid crystal having a carbazole core | Rolic Technologies AG (CH) | 2024-06-18 | — | — | US | disclosed |
| US-12006463-B2 | Polymerizable liquid crystal having a quinoxaline-hydrazone core | Rolic Technologies AG (CH) | 2024-06-11 | — | — | US | disclosed |
| US-11952524-B2 | Compositions of polymerizable liquid crystals | Rolic Technologies AG (CH) | 2024-04-09 | — | — | US | disclosed |
| EP-3175493-B1 | ENCAPSULATION STRUCTURE FOR AN OLED DISPLAY INCORPORATING ANTIREFLECTION PROPERTIES | BASF COATINGS GMBH (DE) | 2024-03-06 | — | — | EP | disclosed |
| EP-3990568-B1 | NEW POLYMERIZABLE LIQUID CRYSTAL HAVING A QUINOXALINE-HYDRAZONE CORE | ROLIC TECH AG (CH) | 2023-11-15 | — | — | EP | disclosed |
| EP-0445629-A2 | Process of preparing liquid crystal compositions containing multiple oriented mesogens | HERCULES INCORPORATED (US) | 1991-09-11 | — | — | EP | disclosed |
| US-5032009-A | Polarized light exposure | HERCULES INCORPORATED (US) | 1991-07-16 | — | — | US | disclosed |
| EP-0432735-A2 | Liquid crystal coupled dichroic dyes | HERCULES INCORPORATED (US) | 1991-06-19 | — | — | EP | disclosed |
| EP-0406812-A2 | Process for the preparation of NiNi-dialkyl-1,8-naphthalene diamine | HERCULES INCORPORATED (US) | 1991-01-09 | — | — | EP | disclosed |
| US-4974941-A | Process of aligning and realigning liquid crystal media | HERCULES INCORPORATED (US) | 1990-12-04 | — | — | US | disclosed |
| EP-0387059-A2 | Process of aligning liquid crystal media | HERCULES INCORPORATED (US) | 1990-09-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12012382-B2 | Polymerizable liquid crystal having a carbazole core | FZD7, CCL11, SGK2 | KDM4A 2694/4885KDM2A 4006/4885AHR 2027/4885 |
| US-12006463-B2 | Polymerizable liquid crystal having a quinoxaline-hydrazone core | AQP1, AQP4, HCN1 | KDM4A 1647/4885KDM2A 2635/4885AHR 3269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.